Saint Louis, MO · Founded 2007 · Privately Held (backing)
Provider of specialty diagnostic testing services intended to offer novel diagnostics for Alzheimer's disease. C2N Diagnostics is based in Saint Louis, MO and was founded in 2007. It has raised $95 million across 2 recorded rounds; the latest was a $10 million early-stage round in May 2025.
Last price · $/share
—
Implied valuation
—
Total raised
$95.0M
Last round
Early Stage VC
May 2025
Team — not yet on record
No current team members for C2N Diagnostics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of C2N Diagnostics with a free account
·Watch C2N Diagnostics: the Monday email on marks, rounds and moves
